1. Home
  2. PMCB vs JCSE Comparison

PMCB vs JCSE Comparison

Compare PMCB & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • JCSE
  • Stock Information
  • Founded
  • PMCB 1996
  • JCSE 1999
  • Country
  • PMCB United States
  • JCSE Singapore
  • Employees
  • PMCB N/A
  • JCSE N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • PMCB Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • PMCB Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • PMCB 7.3M
  • JCSE 5.9M
  • IPO Year
  • PMCB N/A
  • JCSE 2022
  • Fundamental
  • Price
  • PMCB $1.03
  • JCSE $1.07
  • Analyst Decision
  • PMCB
  • JCSE
  • Analyst Count
  • PMCB 0
  • JCSE 0
  • Target Price
  • PMCB N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • PMCB 16.1K
  • JCSE 7.2K
  • Earning Date
  • PMCB 09-16-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • PMCB N/A
  • JCSE 8.49%
  • EPS Growth
  • PMCB N/A
  • JCSE N/A
  • EPS
  • PMCB 1.29
  • JCSE 0.00
  • Revenue
  • PMCB N/A
  • JCSE $14,126,397.00
  • Revenue This Year
  • PMCB N/A
  • JCSE N/A
  • Revenue Next Year
  • PMCB N/A
  • JCSE N/A
  • P/E Ratio
  • PMCB $0.79
  • JCSE $230.58
  • Revenue Growth
  • PMCB N/A
  • JCSE 6.92
  • 52 Week Low
  • PMCB $1.00
  • JCSE $0.71
  • 52 Week High
  • PMCB $2.42
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 41.98
  • JCSE 45.29
  • Support Level
  • PMCB $1.05
  • JCSE $1.02
  • Resistance Level
  • PMCB $1.15
  • JCSE $1.07
  • Average True Range (ATR)
  • PMCB 0.07
  • JCSE 0.04
  • MACD
  • PMCB -0.01
  • JCSE -0.01
  • Stochastic Oscillator
  • PMCB 20.00
  • JCSE 27.78

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: